4Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs [J]. N Engl J Med, 2005, 353:1711 - 1723.
5Schuurmans MM,Botha PR,Steyn D,et al.Glucocorticosteroid reversibility testing with oral prednisone (""steroid trial"") for 4 weeks:time-response study using serial spirometry and 6-minute walk distance (6MWD) in patients with moderate to severe stable CO
6Lindberg A,Larsson LG,Eriksson B,et al.Incidence of COPD in Northern Sweden.Eur Respir J,2004;24:434s
7Soler N,Agusti C,Angrill J,et al.Validation of Anthonisen criteria in infectious COPD exacerbation among patients requiring hospitalization.Eur Respir J,2004;24:411s
8Jaccard-Stolz D,Christ-Crain M,Gencay MM,et al.Indication for antibiotic therapy in AECB:anthonisen's criteria versus procalcitonin.Eur Respir J,2004;24:50s
9van Vliet M,Spruit MA,Kasran A,et al.Determinants of exacerbation rate in patients with stable COPD.Eur Respir J,2004;24:661s
10Winter JE,Wilson AM,Winter JH,et al.Predictors for admission to hospital in patients with chronic obstructive pulmonary disease (COPD).Eur Respir J,2004;24:662s
8Maltais F, Ostinelli J,Tonnel AB ,et al. Comparison of nebulized bodes- onide and oral prednisolone with placebo in the treatment of acute ex- aeerbations of chronic obstructive pulmonary disease:a randomized con- trolled trim respire[J]. Crit Care Med, 2002,165 (5) : 698-703.
9Gunen H,Hacievliyagil SS,Yetkin O,et al. The role of nebulised budesonide in the treatment of exacerbations of COPD [J]. Eur Respir J, 2007,29 (4) : 660-667.
10Casaburi R, Briggs DD, Donohue JF, et al. The spirometricefficacy of once daly dosing with tiotropium in stable COPD:a 13-week multicenter trial. The US Tiotropium Study Group [J]. Chest, 2013,118 (5) : 1294-1302.
